Edition:
United States

Endologix Inc (ELGX.OQ)

ELGX.OQ on NASDAQ Stock Exchange Global Select Market

5.25USD
15 Dec 2017
Change (% chg)

$0.05 (+0.96%)
Prev Close
$5.20
Open
$5.16
Day's High
$5.36
Day's Low
$5.05
Volume
478,324
Avg. Vol
177,347
52-wk High
$7.66
52-wk Low
$4.08

Select another date:

Tue, Nov 7 2017

BRIEF-Endologix Q3 loss per share $0.17

* Q3 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Endologix appoints John Onopchenko as chief operating officer

* Endologix appoints John Onopchenko as chief operating officer Source text for Eikon: Further company coverage:

BRIEF-Endologix says operations not materially affected by Santa Rosa fires‍​

* Comments on impact of the Santa Rosa fires impact on co's facility ‍​

BRIEF-ENDOLOGIX GETS FDA NOD TO BEGIN CONFIRMATORY CLINICAL STUDY ON ITS NELLIX EVAS SYSTEM

* ENDOLOGIX RECEIVES IDE APPROVAL FOR THE EVAS2 CONFIRMATORY CLINICAL STUDY TO EVALUATE THE NELLIX® ENDOVASCULAR ANEURYSM SEALING SYSTEM

BRIEF-Endologix announces CE Mark approval for Nellix Endovascular Aneurysm Sealing System

* Endologix announces CE Mark approval for the Nellix Endovascular Aneurysm Sealing System with the refined indications for use

BRIEF-Endologix announces collaboration agreements with Japan Lifeline

* Endologix announces collaboration agreements with Japan Lifeline for the development and commercialization of thoracic endovascular systems in Japan

BRIEF-Endologix Q2 loss per share $0.20

* Q2 earnings per share view $-0.18 -- Thomson Reuters I/B/E/S

Select another date: